UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by Forsta AP Fonden

Forsta AP Fonden decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 5.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 191,700 shares of the healthcare conglomerate’s stock after selling 12,000 shares during the period. UnitedHealth Group accounts for about 1.1% of Forsta AP Fonden’s holdings, making the stock its 10th biggest holding. Forsta AP Fonden’s holdings in UnitedHealth Group were worth $97,761,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. NorthCrest Asset Manangement LLC lifted its holdings in UnitedHealth Group by 9.5% in the 1st quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock valued at $264,000 after purchasing an additional 45 shares in the last quarter. Domani Wealth LLC lifted its holdings in UnitedHealth Group by 0.7% in the 1st quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock valued at $1,806,000 after purchasing an additional 25 shares in the last quarter. Stratos Wealth Partners LTD. lifted its holdings in UnitedHealth Group by 44.0% in the 1st quarter. Stratos Wealth Partners LTD. now owns 17,711 shares of the healthcare conglomerate’s stock valued at $9,032,000 after purchasing an additional 5,414 shares in the last quarter. Salvus Wealth Management LLC increased its stake in shares of UnitedHealth Group by 23.5% in the 1st quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock worth $399,000 after acquiring an additional 149 shares during the last quarter. Finally, Lake Street Financial LLC increased its stake in shares of UnitedHealth Group by 42.9% in the 1st quarter. Lake Street Financial LLC now owns 3,706 shares of the healthcare conglomerate’s stock worth $1,890,000 after acquiring an additional 1,112 shares during the last quarter. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Credit Suisse Group raised their target price on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Cowen raised their target price on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Argus raised their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Cowen raised their price objective on UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. Finally, Wells Fargo & Company cut their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a research report on Wednesday, May 25th. Three equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $582.50.

UnitedHealth Group Stock Down 0.4 %

Shares of UNH traded down $2.15 during midday trading on Friday, hitting $531.60. The company had a trading volume of 80,190 shares, compared to its average volume of 2,834,317. The company’s 50-day simple moving average is $505.90 and its 200-day simple moving average is $498.93. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77. The firm has a market capitalization of $498.73 billion, a P/E ratio of 27.87, a P/E/G ratio of 1.67 and a beta of 0.76. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s revenue was up 12.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.70 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 21.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were paid a dividend of $1.65 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend was Thursday, June 16th. This represents a $6.60 annualized dividend and a yield of 1.24%. UnitedHealth Group’s payout ratio is presently 34.46%.

Insider Buying and Selling

In other UnitedHealth Group news, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the transaction, the chief financial officer now owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The transaction was disclosed in a filing with the SEC, which is available at this link. In other UnitedHealth Group news, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the transaction, the chief financial officer now owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold a total of 130,144 shares of company stock worth $69,269,555 over the last 90 days. 0.40% of the stock is owned by insiders.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.